Sleep medicine · 2026
Assessment of readiness in the diagnosis and management of central disorders of hypersomnolence: A survey of sleep medicine program directors and fellowship graduates.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kutscher Scott, Schneider Logan D, Parthasarathy Sairam, Fuller Douglas S, Bejou Nika, Candler Shawn
Аннотация
OBJECTIVE/BACKGROUND: Central disorders of hypersomnolence (CDH), including narcolepsy, idiopathic hypersomnia, and recurrent hypersomnia, are rare conditions that pose challenges in sleep medicine fellowship training. Limited exposure to these disorders, variability in training experiences, and growing complexity of diagnostic tools and treatment options contribute to gaps in education. This study aimed to assess perceptions of training adequacy in CDH among sleep medicine program directors and recent fellowship graduates.
PATIENTS/METHODS: A cross-sectional survey was conducted between April 2024 and July 2024 among US board-certified sleep physicians, including program directors contacted through a sleep medicine fellowship program listserv, and their recent fellowship graduates. Surveys assessed perceptions of training in diagnosing and managing CDH, including exposure to diagnostic tools, patient populations, and pharmacological treatments. Responses were summarized using descriptive statistics.
RESULTS: Of 110 program directors contacted, 29 (26.4%) responded, and 48 (6.5%) of 740 eligible graduates participated. Program directors and graduates reported adequate exposure to narcolepsy and idiopathic hypersomnia; exposure to recurrent hypersomnia was lower. Both groups reported confidence in adequacy of training in most diagnostic methods (polysomnography, multiple sleep latency test, and Epworth Sleepiness Scale); confidence with actigraphy was lower. Gaps were identified in training for longitudinal care during medical management of CDH, and exposure to certain medications (eg, lithium) was limited.
CONCLUSIONS: Survey findings demonstrate adequacy of training in diagnosing CDH but suggest some gaps in training regarding rare conditions and advanced treatment and management, highlighting needs for targeted educational resources and standardized curricula.
CLINICAL TRIAL REGISTRATION: Not applicable.
PATIENTS/METHODS: A cross-sectional survey was conducted between April 2024 and July 2024 among US board-certified sleep physicians, including program directors contacted through a sleep medicine fellowship program listserv, and their recent fellowship graduates. Surveys assessed perceptions of training in diagnosing and managing CDH, including exposure to diagnostic tools, patient populations, and pharmacological treatments. Responses were summarized using descriptive statistics.
RESULTS: Of 110 program directors contacted, 29 (26.4%) responded, and 48 (6.5%) of 740 eligible graduates participated. Program directors and graduates reported adequate exposure to narcolepsy and idiopathic hypersomnia; exposure to recurrent hypersomnia was lower. Both groups reported confidence in adequacy of training in most diagnostic methods (polysomnography, multiple sleep latency test, and Epworth Sleepiness Scale); confidence with actigraphy was lower. Gaps were identified in training for longitudinal care during medical management of CDH, and exposure to certain medications (eg, lithium) was limited.
CONCLUSIONS: Survey findings demonstrate adequacy of training in diagnosing CDH but suggest some gaps in training regarding rare conditions and advanced treatment and management, highlighting needs for targeted educational resources and standardized curricula.
CLINICAL TRIAL REGISTRATION: Not applicable.